Decision Aids, Dementia
Conditions
Keywords
Lecanemab
Brief summary
The purpose of this study is to develop a decision aid to support patients and families making decisions about medications for dementia.
Interventions
BEHAVIORALDecision aid
Patients with dementia and care partners will receive an iteration of the decision aid and provide feedback.
Sponsors
National Institute on Aging (NIA)
University of Colorado, Denver
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
This is an iterative, user-centered design process. Therefore, patients and care partners will receive iterations of the decision aid as updates are made to it.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Patients: * UCHealth patient * Ages 18 y/o and above * Documented neurocognitive deficits suggestive of mild cognitive impairment or early dementia as determined by their treating clinician. * English or Spanish speaking Caregiver: * Ages 18 y/o and above * Identified by the study participant as the person who helps the most with their medical care outside the hospital or clinic. * English or Spanish speaking Clinicians: * Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making. * English or Spanish speaking
Exclusion criteria
Patients: * Not English or Spanish-speaking * Neurocognitive deficits suggestive of moderate or severe cognitive impairment or late stage dementia. * Not able to consent for themselves Caregiver: * Ages 17 y/o and below * Not English or Spanish-speaking Clinicians: * Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making. * English or Spanish-speaking
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Decisional Conflict | From enrollment at start of year 2 to the end of year 2 | To access the preliminary efficacy on decisional conflict including personal perceptions of uncertainty in choosing options, factors that contribute to feelings of uncertainty and effective decision making. Decisional Conflict Scale - Higher numbers mean more uncertainty. O'Connor, A. M. (1995). Validation of a decisional conflict scale. Medical decision making, 15(1), 25-30. https://decisionaid.ohri.ca/docs/develop/User\_Manuals/UM\_Decisional\_Conflict.pdf |
| Shared Decision Making | From enrollment at start of year 2 to the end of year 2 | To determine the extent that health care providers engage with patients as a part of their shared decision making, specifically looking at the discussion of treatment options and their pros and cons as well as the patient's preferences. Shared Decision Making Process Scale - Higher numbers mean more shared decision making. https://mghdecisionsciences.org/tools-training/sdm-process-survey/ |
| Decisional Self-Efficacy | From enrollment at start of year 2 to the end of year 2 | To determine the patient's perception of their self-efficacy in decision making including measuring their self-confidence in their ability to make decisions. Decision Self-Efficacy Scale where higher numbers mean they patient has a higher perception of self-efficacy. https://decisionaid.ohri.ca/docs/develop/Tools/Decision\_SelfEfficacy.pdf |
Countries
United States
Contacts
Primary ContactKaitlynn Walton, MPH
Backup ContactKate Noonan, MSW
Outcome results
None listed